nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—ABCB1—Nadolol—hypertension	0.0281	0.0608	CbGbCtD
Carfilzomib—ABCB1—Acebutolol—hypertension	0.0257	0.0556	CbGbCtD
Carfilzomib—ABCB1—Metoprolol—hypertension	0.0239	0.0517	CbGbCtD
Carfilzomib—ABCB1—Candesartan—hypertension	0.0239	0.0517	CbGbCtD
Carfilzomib—ABCB1—Terazosin—hypertension	0.0225	0.0486	CbGbCtD
Carfilzomib—ABCB1—Reserpine—hypertension	0.0213	0.0461	CbGbCtD
Carfilzomib—ABCB1—Perindopril—hypertension	0.0195	0.0422	CbGbCtD
Carfilzomib—ABCB1—Doxazosin—hypertension	0.0187	0.0406	CbGbCtD
Carfilzomib—ABCB1—Nisoldipine—hypertension	0.0187	0.0406	CbGbCtD
Carfilzomib—ABCB1—Diltiazem—hypertension	0.0181	0.0392	CbGbCtD
Carfilzomib—ABCB1—Telmisartan—hypertension	0.017	0.0369	CbGbCtD
Carfilzomib—ABCB1—Bepridil—hypertension	0.0161	0.0349	CbGbCtD
Carfilzomib—ABCB1—Enalapril—hypertension	0.0161	0.0349	CbGbCtD
Carfilzomib—ABCB1—Lisinopril—hypertension	0.0161	0.0349	CbGbCtD
Carfilzomib—ABCB1—Prazosin—hypertension	0.0154	0.0333	CbGbCtD
Carfilzomib—ABCB1—Amlodipine—hypertension	0.0145	0.0313	CbGbCtD
Carfilzomib—ABCB1—Spironolactone—hypertension	0.0142	0.0308	CbGbCtD
Carfilzomib—ABCB1—Felodipine—hypertension	0.014	0.0302	CbGbCtD
Carfilzomib—ABCB1—Timolol—hypertension	0.0137	0.0297	CbGbCtD
Carfilzomib—ABCB1—Nifedipine—hypertension	0.0135	0.0292	CbGbCtD
Carfilzomib—ABCB1—Carvedilol—hypertension	0.0133	0.0288	CbGbCtD
Carfilzomib—ABCB1—Nicardipine—hypertension	0.0133	0.0288	CbGbCtD
Carfilzomib—ABCB1—Propranolol—hypertension	0.0122	0.0265	CbGbCtD
Carfilzomib—ABCB1—Captopril—hypertension	0.0121	0.0262	CbGbCtD
Carfilzomib—ABCB1—Clonidine—hypertension	0.0117	0.0253	CbGbCtD
Carfilzomib—ABCB1—Atorvastatin—hypertension	0.0104	0.0225	CbGbCtD
Carfilzomib—ABCB1—Losartan—hypertension	0.00951	0.0206	CbGbCtD
Carfilzomib—ABCB1—Verapamil—hypertension	0.00839	0.0182	CbGbCtD
Carfilzomib—PSMB10—heart—hypertension	0.00329	0.0364	CbGeAlD
Carfilzomib—PSMB5—cardiac ventricle—hypertension	0.00285	0.0316	CbGeAlD
Carfilzomib—PSMB5—myocardium—hypertension	0.00268	0.0297	CbGeAlD
Carfilzomib—PSMB1—cardiac ventricle—hypertension	0.00249	0.0276	CbGeAlD
Carfilzomib—PSMB10—adrenal gland—hypertension	0.00245	0.0272	CbGeAlD
Carfilzomib—PSMB2—cardiac ventricle—hypertension	0.00243	0.0269	CbGeAlD
Carfilzomib—PSMB1—myocardium—hypertension	0.00234	0.026	CbGeAlD
Carfilzomib—PSMB2—myocardium—hypertension	0.00229	0.0253	CbGeAlD
Carfilzomib—PSMB8—adrenal cortex—hypertension	0.00219	0.0243	CbGeAlD
Carfilzomib—PSMB10—endocrine gland—hypertension	0.00213	0.0236	CbGeAlD
Carfilzomib—PSMB8—heart—hypertension	0.00212	0.0235	CbGeAlD
Carfilzomib—PSMB8—decidua—hypertension	0.00206	0.0228	CbGeAlD
Carfilzomib—PSMB5—nephron tubule—hypertension	0.00197	0.0218	CbGeAlD
Carfilzomib—PSMB5—adrenal cortex—hypertension	0.00193	0.0214	CbGeAlD
Carfilzomib—PSMB10—central nervous system—hypertension	0.00192	0.0212	CbGeAlD
Carfilzomib—PSMB8—cortex of kidney—hypertension	0.0019	0.0211	CbGeAlD
Carfilzomib—PSMB5—heart—hypertension	0.00187	0.0207	CbGeAlD
Carfilzomib—PSMB5—smooth muscle tissue—hypertension	0.00186	0.0206	CbGeAlD
Carfilzomib—PSMB5—decidua—hypertension	0.00182	0.0202	CbGeAlD
Carfilzomib—PSMB8—Fluvastatin—Atorvastatin—hypertension	0.00177	0.578	CbGdCrCtD
Carfilzomib—PSMB1—nephron tubule—hypertension	0.00172	0.019	CbGeAlD
Carfilzomib—PSMB1—adrenal cortex—hypertension	0.00169	0.0187	CbGeAlD
Carfilzomib—PSMB5—cortex of kidney—hypertension	0.00168	0.0186	CbGeAlD
Carfilzomib—PSMB2—nephron tubule—hypertension	0.00168	0.0186	CbGeAlD
Carfilzomib—PSMB2—adrenal cortex—hypertension	0.00165	0.0183	CbGeAlD
Carfilzomib—PSMB1—heart—hypertension	0.00164	0.0181	CbGeAlD
Carfilzomib—PSMB1—smooth muscle tissue—hypertension	0.00162	0.018	CbGeAlD
Carfilzomib—PSMB5—cardiac atrium—hypertension	0.0016	0.0177	CbGeAlD
Carfilzomib—PSMB2—heart—hypertension	0.0016	0.0177	CbGeAlD
Carfilzomib—PSMB1—decidua—hypertension	0.00159	0.0176	CbGeAlD
Carfilzomib—PSMB2—smooth muscle tissue—hypertension	0.00158	0.0175	CbGeAlD
Carfilzomib—PSMB8—adrenal gland—hypertension	0.00158	0.0175	CbGeAlD
Carfilzomib—PSMB2—decidua—hypertension	0.00155	0.0172	CbGeAlD
Carfilzomib—PSMB1—cardiovascular system—hypertension	0.00154	0.0171	CbGeAlD
Carfilzomib—PSMB1—kidney—hypertension	0.00151	0.0167	CbGeAlD
Carfilzomib—PSMB5—medulla oblongata—hypertension	0.00151	0.0167	CbGeAlD
Carfilzomib—PSMB2—cardiovascular system—hypertension	0.00151	0.0167	CbGeAlD
Carfilzomib—PSMB2—kidney—hypertension	0.00147	0.0163	CbGeAlD
Carfilzomib—PSMB1—cortex of kidney—hypertension	0.00147	0.0163	CbGeAlD
Carfilzomib—PSMB2—cortex of kidney—hypertension	0.00143	0.0159	CbGeAlD
Carfilzomib—Ritonavir—ABCC1—hypertension	0.00141	0.622	CrCbGaD
Carfilzomib—PSMB1—cardiac atrium—hypertension	0.0014	0.0155	CbGeAlD
Carfilzomib—PSMB5—adrenal gland—hypertension	0.0014	0.0155	CbGeAlD
Carfilzomib—PSMB2—cardiac atrium—hypertension	0.00136	0.0151	CbGeAlD
Carfilzomib—PSMB1—medulla oblongata—hypertension	0.00132	0.0146	CbGeAlD
Carfilzomib—PSMB2—medulla oblongata—hypertension	0.00129	0.0143	CbGeAlD
Carfilzomib—PSMB1—adrenal gland—hypertension	0.00122	0.0135	CbGeAlD
Carfilzomib—PSMB2—adrenal gland—hypertension	0.00119	0.0132	CbGeAlD
Carfilzomib—PSMB1—endocrine gland—hypertension	0.00106	0.0117	CbGeAlD
Carfilzomib—PSMB2—endocrine gland—hypertension	0.00103	0.0114	CbGeAlD
Carfilzomib—PSMB1—central nervous system—hypertension	0.000954	0.0106	CbGeAlD
Carfilzomib—PSMB2—central nervous system—hypertension	0.000931	0.0103	CbGeAlD
Carfilzomib—Ritonavir—CYP3A5—hypertension	0.000856	0.379	CrCbGaD
Carfilzomib—PSMB8—Testosterone Propionate—Eplerenone—hypertension	0.000689	0.225	CbGdCrCtD
Carfilzomib—PSMB8—Testosterone Propionate—Spironolactone—hypertension	0.000599	0.196	CbGdCrCtD
Carfilzomib—ABCB1—blood vessel—hypertension	0.000516	0.00572	CbGeAlD
Carfilzomib—ABCB1—nephron tubule—hypertension	0.000256	0.00284	CbGeAlD
Carfilzomib—ABCB1—adrenal cortex—hypertension	0.000252	0.00279	CbGeAlD
Carfilzomib—ABCB1—heart—hypertension	0.000244	0.0027	CbGeAlD
Carfilzomib—ABCB1—decidua—hypertension	0.000237	0.00263	CbGeAlD
Carfilzomib—ABCB1—cardiovascular system—hypertension	0.00023	0.00255	CbGeAlD
Carfilzomib—ABCB1—kidney—hypertension	0.000225	0.00249	CbGeAlD
Carfilzomib—ABCB1—cortex of kidney—hypertension	0.000219	0.00243	CbGeAlD
Carfilzomib—ABCB1—medulla oblongata—hypertension	0.000197	0.00218	CbGeAlD
Carfilzomib—ABCB1—adrenal gland—hypertension	0.000182	0.00202	CbGeAlD
Carfilzomib—ABCB1—endocrine gland—hypertension	0.000158	0.00175	CbGeAlD
Carfilzomib—ABCB1—central nervous system—hypertension	0.000142	0.00158	CbGeAlD
Carfilzomib—Chills—Lisinopril—hypertension	9.38e-05	0.000368	CcSEcCtD
Carfilzomib—Asthenia—Doxazosin—hypertension	9.38e-05	0.000368	CcSEcCtD
Carfilzomib—Decreased appetite—Telmisartan—hypertension	9.38e-05	0.000368	CcSEcCtD
Carfilzomib—Thrombocytopenia—Losartan—hypertension	9.35e-05	0.000367	CcSEcCtD
Carfilzomib—Constipation—Enalapril—hypertension	9.35e-05	0.000367	CcSEcCtD
Carfilzomib—Dyspnoea—Captopril—hypertension	9.35e-05	0.000367	CcSEcCtD
Carfilzomib—Anorexia—Betaxolol—hypertension	9.34e-05	0.000366	CcSEcCtD
Carfilzomib—Fatigue—Telmisartan—hypertension	9.3e-05	0.000365	CcSEcCtD
Carfilzomib—Body temperature increased—Olmesartan—hypertension	9.29e-05	0.000364	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Perindopril—hypertension	9.28e-05	0.000364	CcSEcCtD
Carfilzomib—Asthenia—Fosinopril—hypertension	9.27e-05	0.000363	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Irbesartan—hypertension	9.25e-05	0.000363	CcSEcCtD
Carfilzomib—Pain—Telmisartan—hypertension	9.23e-05	0.000362	CcSEcCtD
Carfilzomib—Constipation—Telmisartan—hypertension	9.23e-05	0.000362	CcSEcCtD
Carfilzomib—Insomnia—Perindopril—hypertension	9.21e-05	0.000361	CcSEcCtD
Carfilzomib—Asthenia—Eplerenone—hypertension	9.21e-05	0.000361	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Hydrochlorothiazide—hypertension	9.17e-05	0.00036	CcSEcCtD
Carfilzomib—Asthenia—Nifedipine—hypertension	9.14e-05	0.000358	CcSEcCtD
Carfilzomib—Diarrhoea—Indapamide—hypertension	9.13e-05	0.000358	CcSEcCtD
Carfilzomib—Diarrhoea—Diltiazem—hypertension	9.13e-05	0.000358	CcSEcCtD
Carfilzomib—Dizziness—Propranolol—hypertension	9.12e-05	0.000358	CcSEcCtD
Carfilzomib—Decreased appetite—Captopril—hypertension	9.12e-05	0.000357	CcSEcCtD
Carfilzomib—Anorexia—Losartan—hypertension	9.11e-05	0.000357	CcSEcCtD
Carfilzomib—Insomnia—Hydrochlorothiazide—hypertension	9.11e-05	0.000357	CcSEcCtD
Carfilzomib—Asthenia—Verapamil—hypertension	9.1e-05	0.000357	CcSEcCtD
Carfilzomib—Dyspnoea—Perindopril—hypertension	9.08e-05	0.000356	CcSEcCtD
Carfilzomib—Dyspnoea—Irbesartan—hypertension	9.05e-05	0.000355	CcSEcCtD
Carfilzomib—Diarrhoea—Carvedilol—hypertension	9.05e-05	0.000355	CcSEcCtD
Carfilzomib—Fatigue—Captopril—hypertension	9.04e-05	0.000355	CcSEcCtD
Carfilzomib—Leukopenia—Ramipril—hypertension	8.98e-05	0.000352	CcSEcCtD
Carfilzomib—Dyspnoea—Hydrochlorothiazide—hypertension	8.98e-05	0.000352	CcSEcCtD
Carfilzomib—Constipation—Captopril—hypertension	8.97e-05	0.000352	CcSEcCtD
Carfilzomib—Diarrhoea—Doxazosin—hypertension	8.95e-05	0.000351	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Betaxolol—hypertension	8.93e-05	0.00035	CcSEcCtD
Carfilzomib—Nausea—Guanabenz—hypertension	8.92e-05	0.00035	CcSEcCtD
Carfilzomib—Nausea—Metoprolol—hypertension	8.92e-05	0.00035	CcSEcCtD
Carfilzomib—Body temperature increased—Clonidine—hypertension	8.9e-05	0.000349	CcSEcCtD
Carfilzomib—Insomnia—Betaxolol—hypertension	8.87e-05	0.000348	CcSEcCtD
Carfilzomib—Decreased appetite—Perindopril—hypertension	8.85e-05	0.000347	CcSEcCtD
Carfilzomib—Diarrhoea—Fosinopril—hypertension	8.84e-05	0.000346	CcSEcCtD
Carfilzomib—Dizziness—Indapamide—hypertension	8.83e-05	0.000346	CcSEcCtD
Carfilzomib—Dizziness—Diltiazem—hypertension	8.83e-05	0.000346	CcSEcCtD
Carfilzomib—Decreased appetite—Irbesartan—hypertension	8.82e-05	0.000346	CcSEcCtD
Carfilzomib—Back pain—Lisinopril—hypertension	8.81e-05	0.000345	CcSEcCtD
Carfilzomib—Diarrhoea—Eplerenone—hypertension	8.78e-05	0.000344	CcSEcCtD
Carfilzomib—Fatigue—Perindopril—hypertension	8.78e-05	0.000344	CcSEcCtD
Carfilzomib—Vomiting—Propranolol—hypertension	8.77e-05	0.000344	CcSEcCtD
Carfilzomib—Cough—Ramipril—hypertension	8.76e-05	0.000343	CcSEcCtD
Carfilzomib—Decreased appetite—Hydrochlorothiazide—hypertension	8.75e-05	0.000343	CcSEcCtD
Carfilzomib—Fatigue—Irbesartan—hypertension	8.75e-05	0.000343	CcSEcCtD
Carfilzomib—Muscle spasms—Lisinopril—hypertension	8.75e-05	0.000343	CcSEcCtD
Carfilzomib—Dizziness—Carvedilol—hypertension	8.74e-05	0.000343	CcSEcCtD
Carfilzomib—Dyspnoea—Betaxolol—hypertension	8.74e-05	0.000343	CcSEcCtD
Carfilzomib—Diarrhoea—Nifedipine—hypertension	8.72e-05	0.000342	CcSEcCtD
Carfilzomib—Pain—Perindopril—hypertension	8.71e-05	0.000341	CcSEcCtD
Carfilzomib—Constipation—Perindopril—hypertension	8.71e-05	0.000341	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Losartan—hypertension	8.7e-05	0.000341	CcSEcCtD
Carfilzomib—Body temperature increased—Trandolapril—hypertension	8.68e-05	0.00034	CcSEcCtD
Carfilzomib—Diarrhoea—Verapamil—hypertension	8.68e-05	0.00034	CcSEcCtD
Carfilzomib—Constipation—Irbesartan—hypertension	8.68e-05	0.00034	CcSEcCtD
Carfilzomib—Pain—Irbesartan—hypertension	8.68e-05	0.00034	CcSEcCtD
Carfilzomib—Fatigue—Hydrochlorothiazide—hypertension	8.68e-05	0.00034	CcSEcCtD
Carfilzomib—Dizziness—Doxazosin—hypertension	8.65e-05	0.000339	CcSEcCtD
Carfilzomib—Body temperature increased—Enalapril—hypertension	8.65e-05	0.000339	CcSEcCtD
Carfilzomib—Insomnia—Losartan—hypertension	8.64e-05	0.000339	CcSEcCtD
Carfilzomib—Pain—Hydrochlorothiazide—hypertension	8.61e-05	0.000338	CcSEcCtD
Carfilzomib—Constipation—Hydrochlorothiazide—hypertension	8.61e-05	0.000338	CcSEcCtD
Carfilzomib—Decreased appetite—Furosemide—hypertension	8.61e-05	0.000337	CcSEcCtD
Carfilzomib—Cough—Timolol—hypertension	8.56e-05	0.000336	CcSEcCtD
Carfilzomib—Arthralgia—Ramipril—hypertension	8.55e-05	0.000335	CcSEcCtD
Carfilzomib—Dizziness—Fosinopril—hypertension	8.54e-05	0.000335	CcSEcCtD
Carfilzomib—Fatigue—Furosemide—hypertension	8.54e-05	0.000335	CcSEcCtD
Carfilzomib—Body temperature increased—Telmisartan—hypertension	8.53e-05	0.000334	CcSEcCtD
Carfilzomib—Decreased appetite—Betaxolol—hypertension	8.52e-05	0.000334	CcSEcCtD
Carfilzomib—Dyspnoea—Losartan—hypertension	8.52e-05	0.000334	CcSEcCtD
Carfilzomib—Dizziness—Eplerenone—hypertension	8.49e-05	0.000333	CcSEcCtD
Carfilzomib—Vomiting—Diltiazem—hypertension	8.49e-05	0.000333	CcSEcCtD
Carfilzomib—Vomiting—Indapamide—hypertension	8.49e-05	0.000333	CcSEcCtD
Carfilzomib—Asthenia—Valsartan—hypertension	8.48e-05	0.000332	CcSEcCtD
Carfilzomib—Hypertension—Timolol—hypertension	8.47e-05	0.000332	CcSEcCtD
Carfilzomib—Constipation—Furosemide—hypertension	8.47e-05	0.000332	CcSEcCtD
Carfilzomib—Pain—Furosemide—hypertension	8.47e-05	0.000332	CcSEcCtD
Carfilzomib—Fatigue—Betaxolol—hypertension	8.45e-05	0.000331	CcSEcCtD
Carfilzomib—Asthenia—Olmesartan—hypertension	8.43e-05	0.000331	CcSEcCtD
Carfilzomib—Dizziness—Nifedipine—hypertension	8.43e-05	0.00033	CcSEcCtD
Carfilzomib—Anaemia—Lisinopril—hypertension	8.41e-05	0.00033	CcSEcCtD
Carfilzomib—Vomiting—Carvedilol—hypertension	8.41e-05	0.00033	CcSEcCtD
Carfilzomib—Dizziness—Verapamil—hypertension	8.39e-05	0.000329	CcSEcCtD
Carfilzomib—Constipation—Betaxolol—hypertension	8.38e-05	0.000329	CcSEcCtD
Carfilzomib—Pain—Betaxolol—hypertension	8.38e-05	0.000329	CcSEcCtD
Carfilzomib—Headache—Diltiazem—hypertension	8.36e-05	0.000328	CcSEcCtD
Carfilzomib—Headache—Indapamide—hypertension	8.36e-05	0.000328	CcSEcCtD
Carfilzomib—Arthralgia—Timolol—hypertension	8.35e-05	0.000327	CcSEcCtD
Carfilzomib—Vomiting—Doxazosin—hypertension	8.31e-05	0.000326	CcSEcCtD
Carfilzomib—Decreased appetite—Losartan—hypertension	8.3e-05	0.000326	CcSEcCtD
Carfilzomib—Body temperature increased—Captopril—hypertension	8.29e-05	0.000325	CcSEcCtD
Carfilzomib—Headache—Carvedilol—hypertension	8.28e-05	0.000325	CcSEcCtD
Carfilzomib—Fatigue—Losartan—hypertension	8.24e-05	0.000323	CcSEcCtD
Carfilzomib—Vomiting—Fosinopril—hypertension	8.21e-05	0.000322	CcSEcCtD
Carfilzomib—Nausea—Propranolol—hypertension	8.19e-05	0.000321	CcSEcCtD
Carfilzomib—Headache—Doxazosin—hypertension	8.19e-05	0.000321	CcSEcCtD
Carfilzomib—Constipation—Losartan—hypertension	8.17e-05	0.00032	CcSEcCtD
Carfilzomib—Pain—Losartan—hypertension	8.17e-05	0.00032	CcSEcCtD
Carfilzomib—Vomiting—Eplerenone—hypertension	8.16e-05	0.00032	CcSEcCtD
Carfilzomib—Leukopenia—Lisinopril—hypertension	8.15e-05	0.000319	CcSEcCtD
Carfilzomib—Vomiting—Nifedipine—hypertension	8.1e-05	0.000318	CcSEcCtD
Carfilzomib—Headache—Fosinopril—hypertension	8.09e-05	0.000317	CcSEcCtD
Carfilzomib—Diarrhoea—Valsartan—hypertension	8.08e-05	0.000317	CcSEcCtD
Carfilzomib—Asthenia—Clonidine—hypertension	8.08e-05	0.000317	CcSEcCtD
Carfilzomib—Vomiting—Verapamil—hypertension	8.07e-05	0.000316	CcSEcCtD
Carfilzomib—Body temperature increased—Perindopril—hypertension	8.05e-05	0.000316	CcSEcCtD
Carfilzomib—Diarrhoea—Olmesartan—hypertension	8.04e-05	0.000315	CcSEcCtD
Carfilzomib—Headache—Eplerenone—hypertension	8.04e-05	0.000315	CcSEcCtD
Carfilzomib—Body temperature increased—Irbesartan—hypertension	8.03e-05	0.000315	CcSEcCtD
Carfilzomib—Thrombocytopenia—Ramipril—hypertension	8.02e-05	0.000314	CcSEcCtD
Carfilzomib—Headache—Nifedipine—hypertension	7.98e-05	0.000313	CcSEcCtD
Carfilzomib—Body temperature increased—Hydrochlorothiazide—hypertension	7.96e-05	0.000312	CcSEcCtD
Carfilzomib—Infection—Timolol—hypertension	7.96e-05	0.000312	CcSEcCtD
Carfilzomib—Headache—Verapamil—hypertension	7.95e-05	0.000312	CcSEcCtD
Carfilzomib—Cough—Lisinopril—hypertension	7.94e-05	0.000311	CcSEcCtD
Carfilzomib—Nausea—Diltiazem—hypertension	7.93e-05	0.000311	CcSEcCtD
Carfilzomib—Nausea—Indapamide—hypertension	7.93e-05	0.000311	CcSEcCtD
Carfilzomib—Asthenia—Trandolapril—hypertension	7.88e-05	0.000309	CcSEcCtD
Carfilzomib—Nausea—Carvedilol—hypertension	7.85e-05	0.000308	CcSEcCtD
Carfilzomib—Asthenia—Enalapril—hypertension	7.85e-05	0.000308	CcSEcCtD
Carfilzomib—Body temperature increased—Furosemide—hypertension	7.83e-05	0.000307	CcSEcCtD
Carfilzomib—Dizziness—Valsartan—hypertension	7.81e-05	0.000306	CcSEcCtD
Carfilzomib—Anorexia—Ramipril—hypertension	7.81e-05	0.000306	CcSEcCtD
Carfilzomib—Dizziness—Olmesartan—hypertension	7.77e-05	0.000305	CcSEcCtD
Carfilzomib—Nausea—Doxazosin—hypertension	7.77e-05	0.000304	CcSEcCtD
Carfilzomib—Arthralgia—Lisinopril—hypertension	7.75e-05	0.000304	CcSEcCtD
Carfilzomib—Body temperature increased—Betaxolol—hypertension	7.75e-05	0.000304	CcSEcCtD
Carfilzomib—Asthenia—Telmisartan—hypertension	7.74e-05	0.000303	CcSEcCtD
Carfilzomib—Diarrhoea—Clonidine—hypertension	7.7e-05	0.000302	CcSEcCtD
Carfilzomib—Nausea—Fosinopril—hypertension	7.67e-05	0.000301	CcSEcCtD
Carfilzomib—Anorexia—Timolol—hypertension	7.63e-05	0.000299	CcSEcCtD
Carfilzomib—Nausea—Eplerenone—hypertension	7.63e-05	0.000299	CcSEcCtD
Carfilzomib—Nausea—Nifedipine—hypertension	7.57e-05	0.000297	CcSEcCtD
Carfilzomib—Body temperature increased—Losartan—hypertension	7.55e-05	0.000296	CcSEcCtD
Carfilzomib—Nausea—Verapamil—hypertension	7.54e-05	0.000295	CcSEcCtD
Carfilzomib—Asthenia—Captopril—hypertension	7.53e-05	0.000295	CcSEcCtD
Carfilzomib—Diarrhoea—Trandolapril—hypertension	7.51e-05	0.000295	CcSEcCtD
Carfilzomib—Vomiting—Valsartan—hypertension	7.51e-05	0.000294	CcSEcCtD
Carfilzomib—Diarrhoea—Enalapril—hypertension	7.48e-05	0.000293	CcSEcCtD
Carfilzomib—Vomiting—Olmesartan—hypertension	7.47e-05	0.000293	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Ramipril—hypertension	7.46e-05	0.000293	CcSEcCtD
Carfilzomib—Dizziness—Clonidine—hypertension	7.45e-05	0.000292	CcSEcCtD
Carfilzomib—Insomnia—Ramipril—hypertension	7.41e-05	0.00029	CcSEcCtD
Carfilzomib—Headache—Valsartan—hypertension	7.4e-05	0.00029	CcSEcCtD
Carfilzomib—Diarrhoea—Telmisartan—hypertension	7.38e-05	0.000289	CcSEcCtD
Carfilzomib—Infection—Lisinopril—hypertension	7.38e-05	0.000289	CcSEcCtD
Carfilzomib—Headache—Olmesartan—hypertension	7.36e-05	0.000289	CcSEcCtD
Carfilzomib—Asthenia—Perindopril—hypertension	7.31e-05	0.000286	CcSEcCtD
Carfilzomib—Dyspnoea—Ramipril—hypertension	7.3e-05	0.000286	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Timolol—hypertension	7.3e-05	0.000286	CcSEcCtD
Carfilzomib—Asthenia—Irbesartan—hypertension	7.28e-05	0.000286	CcSEcCtD
Carfilzomib—Thrombocytopenia—Lisinopril—hypertension	7.27e-05	0.000285	CcSEcCtD
Carfilzomib—Dizziness—Trandolapril—hypertension	7.26e-05	0.000285	CcSEcCtD
Carfilzomib—Insomnia—Timolol—hypertension	7.24e-05	0.000284	CcSEcCtD
Carfilzomib—Dizziness—Enalapril—hypertension	7.23e-05	0.000284	CcSEcCtD
Carfilzomib—Asthenia—Hydrochlorothiazide—hypertension	7.22e-05	0.000283	CcSEcCtD
Carfilzomib—Diarrhoea—Captopril—hypertension	7.18e-05	0.000281	CcSEcCtD
Carfilzomib—Vomiting—Clonidine—hypertension	7.16e-05	0.000281	CcSEcCtD
Carfilzomib—Dyspnoea—Timolol—hypertension	7.14e-05	0.00028	CcSEcCtD
Carfilzomib—Dizziness—Telmisartan—hypertension	7.13e-05	0.00028	CcSEcCtD
Carfilzomib—Decreased appetite—Ramipril—hypertension	7.12e-05	0.000279	CcSEcCtD
Carfilzomib—Asthenia—Furosemide—hypertension	7.1e-05	0.000278	CcSEcCtD
Carfilzomib—Anorexia—Lisinopril—hypertension	7.08e-05	0.000278	CcSEcCtD
Carfilzomib—Fatigue—Ramipril—hypertension	7.06e-05	0.000277	CcSEcCtD
Carfilzomib—Headache—Clonidine—hypertension	7.05e-05	0.000277	CcSEcCtD
Carfilzomib—Asthenia—Betaxolol—hypertension	7.03e-05	0.000276	CcSEcCtD
Carfilzomib—Nausea—Valsartan—hypertension	7.02e-05	0.000275	CcSEcCtD
Carfilzomib—Constipation—Ramipril—hypertension	7.01e-05	0.000275	CcSEcCtD
Carfilzomib—Nausea—Olmesartan—hypertension	6.98e-05	0.000274	CcSEcCtD
Carfilzomib—Vomiting—Trandolapril—hypertension	6.98e-05	0.000274	CcSEcCtD
Carfilzomib—Diarrhoea—Perindopril—hypertension	6.97e-05	0.000273	CcSEcCtD
Carfilzomib—Decreased appetite—Timolol—hypertension	6.96e-05	0.000273	CcSEcCtD
Carfilzomib—Vomiting—Enalapril—hypertension	6.95e-05	0.000273	CcSEcCtD
Carfilzomib—Diarrhoea—Irbesartan—hypertension	6.95e-05	0.000272	CcSEcCtD
Carfilzomib—Dizziness—Captopril—hypertension	6.94e-05	0.000272	CcSEcCtD
Carfilzomib—Fatigue—Timolol—hypertension	6.9e-05	0.000271	CcSEcCtD
Carfilzomib—Diarrhoea—Hydrochlorothiazide—hypertension	6.89e-05	0.00027	CcSEcCtD
Carfilzomib—Headache—Trandolapril—hypertension	6.88e-05	0.00027	CcSEcCtD
Carfilzomib—Vomiting—Telmisartan—hypertension	6.86e-05	0.000269	CcSEcCtD
Carfilzomib—Asthenia—Losartan—hypertension	6.85e-05	0.000269	CcSEcCtD
Carfilzomib—Headache—Enalapril—hypertension	6.85e-05	0.000269	CcSEcCtD
Carfilzomib—Pain—Timolol—hypertension	6.85e-05	0.000268	CcSEcCtD
Carfilzomib—Diarrhoea—Furosemide—hypertension	6.77e-05	0.000266	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Lisinopril—hypertension	6.77e-05	0.000265	CcSEcCtD
Carfilzomib—Headache—Telmisartan—hypertension	6.76e-05	0.000265	CcSEcCtD
Carfilzomib—Dizziness—Perindopril—hypertension	6.74e-05	0.000264	CcSEcCtD
Carfilzomib—Insomnia—Lisinopril—hypertension	6.72e-05	0.000263	CcSEcCtD
Carfilzomib—Dizziness—Irbesartan—hypertension	6.71e-05	0.000263	CcSEcCtD
Carfilzomib—Diarrhoea—Betaxolol—hypertension	6.71e-05	0.000263	CcSEcCtD
Carfilzomib—Nausea—Clonidine—hypertension	6.69e-05	0.000262	CcSEcCtD
Carfilzomib—Vomiting—Captopril—hypertension	6.67e-05	0.000261	CcSEcCtD
Carfilzomib—Dizziness—Hydrochlorothiazide—hypertension	6.66e-05	0.000261	CcSEcCtD
Carfilzomib—Dyspnoea—Lisinopril—hypertension	6.62e-05	0.00026	CcSEcCtD
Carfilzomib—Headache—Captopril—hypertension	6.57e-05	0.000258	CcSEcCtD
Carfilzomib—Dizziness—Furosemide—hypertension	6.55e-05	0.000257	CcSEcCtD
Carfilzomib—Diarrhoea—Losartan—hypertension	6.54e-05	0.000256	CcSEcCtD
Carfilzomib—Nausea—Trandolapril—hypertension	6.52e-05	0.000256	CcSEcCtD
Carfilzomib—Nausea—Enalapril—hypertension	6.5e-05	0.000255	CcSEcCtD
Carfilzomib—Dizziness—Betaxolol—hypertension	6.48e-05	0.000254	CcSEcCtD
Carfilzomib—Vomiting—Perindopril—hypertension	6.48e-05	0.000254	CcSEcCtD
Carfilzomib—Body temperature increased—Ramipril—hypertension	6.48e-05	0.000254	CcSEcCtD
Carfilzomib—Decreased appetite—Lisinopril—hypertension	6.46e-05	0.000253	CcSEcCtD
Carfilzomib—Vomiting—Irbesartan—hypertension	6.45e-05	0.000253	CcSEcCtD
Carfilzomib—Nausea—Telmisartan—hypertension	6.41e-05	0.000251	CcSEcCtD
Carfilzomib—Fatigue—Lisinopril—hypertension	6.41e-05	0.000251	CcSEcCtD
Carfilzomib—Vomiting—Hydrochlorothiazide—hypertension	6.4e-05	0.000251	CcSEcCtD
Carfilzomib—Headache—Perindopril—hypertension	6.38e-05	0.00025	CcSEcCtD
Carfilzomib—Headache—Irbesartan—hypertension	6.36e-05	0.000249	CcSEcCtD
Carfilzomib—Pain—Lisinopril—hypertension	6.35e-05	0.000249	CcSEcCtD
Carfilzomib—Constipation—Lisinopril—hypertension	6.35e-05	0.000249	CcSEcCtD
Carfilzomib—Body temperature increased—Timolol—hypertension	6.33e-05	0.000248	CcSEcCtD
Carfilzomib—Dizziness—Losartan—hypertension	6.32e-05	0.000248	CcSEcCtD
Carfilzomib—Headache—Hydrochlorothiazide—hypertension	6.31e-05	0.000247	CcSEcCtD
Carfilzomib—Vomiting—Furosemide—hypertension	6.3e-05	0.000247	CcSEcCtD
Carfilzomib—Vomiting—Betaxolol—hypertension	6.23e-05	0.000244	CcSEcCtD
Carfilzomib—Nausea—Captopril—hypertension	6.23e-05	0.000244	CcSEcCtD
Carfilzomib—Headache—Furosemide—hypertension	6.2e-05	0.000243	CcSEcCtD
Carfilzomib—Headache—Betaxolol—hypertension	6.14e-05	0.000241	CcSEcCtD
Carfilzomib—Vomiting—Losartan—hypertension	6.07e-05	0.000238	CcSEcCtD
Carfilzomib—Nausea—Perindopril—hypertension	6.05e-05	0.000237	CcSEcCtD
Carfilzomib—Nausea—Irbesartan—hypertension	6.03e-05	0.000236	CcSEcCtD
Carfilzomib—Headache—Losartan—hypertension	5.99e-05	0.000235	CcSEcCtD
Carfilzomib—Nausea—Hydrochlorothiazide—hypertension	5.98e-05	0.000234	CcSEcCtD
Carfilzomib—Nausea—Furosemide—hypertension	5.88e-05	0.000231	CcSEcCtD
Carfilzomib—Asthenia—Ramipril—hypertension	5.88e-05	0.00023	CcSEcCtD
Carfilzomib—Body temperature increased—Lisinopril—hypertension	5.87e-05	0.00023	CcSEcCtD
Carfilzomib—Nausea—Betaxolol—hypertension	5.82e-05	0.000228	CcSEcCtD
Carfilzomib—Asthenia—Timolol—hypertension	5.75e-05	0.000225	CcSEcCtD
Carfilzomib—Nausea—Losartan—hypertension	5.67e-05	0.000222	CcSEcCtD
Carfilzomib—Diarrhoea—Ramipril—hypertension	5.6e-05	0.00022	CcSEcCtD
Carfilzomib—Diarrhoea—Timolol—hypertension	5.48e-05	0.000215	CcSEcCtD
Carfilzomib—Dizziness—Ramipril—hypertension	5.42e-05	0.000212	CcSEcCtD
Carfilzomib—Asthenia—Lisinopril—hypertension	5.33e-05	0.000209	CcSEcCtD
Carfilzomib—Dizziness—Timolol—hypertension	5.3e-05	0.000208	CcSEcCtD
Carfilzomib—Vomiting—Ramipril—hypertension	5.21e-05	0.000204	CcSEcCtD
Carfilzomib—Headache—Ramipril—hypertension	5.13e-05	0.000201	CcSEcCtD
Carfilzomib—Vomiting—Timolol—hypertension	5.09e-05	0.0002	CcSEcCtD
Carfilzomib—Diarrhoea—Lisinopril—hypertension	5.08e-05	0.000199	CcSEcCtD
Carfilzomib—Headache—Timolol—hypertension	5.02e-05	0.000197	CcSEcCtD
Carfilzomib—Dizziness—Lisinopril—hypertension	4.91e-05	0.000193	CcSEcCtD
Carfilzomib—Nausea—Ramipril—hypertension	4.87e-05	0.000191	CcSEcCtD
Carfilzomib—Nausea—Timolol—hypertension	4.76e-05	0.000186	CcSEcCtD
Carfilzomib—Vomiting—Lisinopril—hypertension	4.72e-05	0.000185	CcSEcCtD
Carfilzomib—Headache—Lisinopril—hypertension	4.65e-05	0.000182	CcSEcCtD
Carfilzomib—Nausea—Lisinopril—hypertension	4.41e-05	0.000173	CcSEcCtD
Carfilzomib—PSMB1—Signaling Pathways—AKT2—hypertension	5.97e-06	3.19e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—AKT2—hypertension	5.97e-06	3.19e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PTGS2—hypertension	5.93e-06	3.16e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PTGS2—hypertension	5.93e-06	3.16e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PTGS2—hypertension	5.93e-06	3.16e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IGF1—hypertension	5.89e-06	3.14e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—AKT2—hypertension	5.89e-06	3.14e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—EP300—hypertension	5.88e-06	3.14e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—EP300—hypertension	5.88e-06	3.14e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—EP300—hypertension	5.88e-06	3.14e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PTGS2—hypertension	5.84e-06	3.12e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—EP300—hypertension	5.8e-06	3.1e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HSPG2—hypertension	5.78e-06	3.08e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MMP9—hypertension	5.74e-06	3.06e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—PPARA—hypertension	5.72e-06	3.05e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—SRC—hypertension	5.72e-06	3.05e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—SRC—hypertension	5.72e-06	3.05e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—SRC—hypertension	5.72e-06	3.05e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CDKN1A—hypertension	5.71e-06	3.05e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MMP9—hypertension	5.71e-06	3.04e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—PTEN—hypertension	5.7e-06	3.04e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CDKN1A—hypertension	5.69e-06	3.03e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—PTEN—hypertension	5.67e-06	3.03e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—SERPINE1—hypertension	5.67e-06	3.03e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—SERPINE1—hypertension	5.67e-06	3.03e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—SERPINE1—hypertension	5.67e-06	3.03e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—SRC—hypertension	5.64e-06	3.01e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—SERPINE1—hypertension	5.59e-06	2.98e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALOX5—hypertension	5.58e-06	2.98e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GLP1R—hypertension	5.58e-06	2.98e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hypertension	5.58e-06	2.98e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MAPK8—hypertension	5.58e-06	2.98e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MAPK8—hypertension	5.55e-06	2.96e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—MYC—hypertension	5.52e-06	2.95e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—MYC—hypertension	5.52e-06	2.95e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—MYC—hypertension	5.52e-06	2.95e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL6—hypertension	5.51e-06	2.94e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—FGF2—hypertension	5.49e-06	2.93e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—FGF2—hypertension	5.49e-06	2.93e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—FGF2—hypertension	5.49e-06	2.93e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL6—hypertension	5.48e-06	2.92e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—RHOA—hypertension	5.47e-06	2.92e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—RHOA—hypertension	5.47e-06	2.92e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—RHOA—hypertension	5.47e-06	2.92e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—MYC—hypertension	5.45e-06	2.9e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—EP300—hypertension	5.44e-06	2.9e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—EGFR—hypertension	5.43e-06	2.9e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—EGFR—hypertension	5.43e-06	2.9e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—EGFR—hypertension	5.43e-06	2.9e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PIK3R1—hypertension	5.42e-06	2.89e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PIK3R1—hypertension	5.42e-06	2.89e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PIK3R1—hypertension	5.42e-06	2.89e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NOS3—hypertension	5.42e-06	2.89e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NOS3—hypertension	5.42e-06	2.89e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NOS3—hypertension	5.42e-06	2.89e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—FGF2—hypertension	5.42e-06	2.89e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—EP300—hypertension	5.41e-06	2.89e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—RHOA—hypertension	5.4e-06	2.88e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—APOA1—hypertension	5.37e-06	2.86e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—EGFR—hypertension	5.36e-06	2.86e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PIK3R1—hypertension	5.34e-06	2.85e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NOS3—hypertension	5.34e-06	2.85e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—SRC—hypertension	5.29e-06	2.82e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—SRC—hypertension	5.26e-06	2.81e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PTEN—hypertension	5.17e-06	2.76e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PTEN—hypertension	5.17e-06	2.76e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PTEN—hypertension	5.17e-06	2.76e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—VEGFA—hypertension	5.15e-06	2.75e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—MYC—hypertension	5.13e-06	2.74e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—MYC—hypertension	5.13e-06	2.74e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—MYC—hypertension	5.13e-06	2.74e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—VEGFA—hypertension	5.13e-06	2.73e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—TGFB1—hypertension	5.12e-06	2.73e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—TGFB1—hypertension	5.12e-06	2.73e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—TGFB1—hypertension	5.12e-06	2.73e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALDH2—hypertension	5.1e-06	2.72e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—RELA—hypertension	5.1e-06	2.72e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—RELA—hypertension	5.1e-06	2.72e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—RELA—hypertension	5.1e-06	2.72e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PTEN—hypertension	5.09e-06	2.72e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—IL6—hypertension	5.09e-06	2.71e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—AKT1—hypertension	5.08e-06	2.71e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—IL6—hypertension	5.06e-06	2.7e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—AKT1—hypertension	5.06e-06	2.7e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—MYC—hypertension	5.06e-06	2.7e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Gene Expression—AKT1—hypertension	5.05e-06	2.7e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—TGFB1—hypertension	5.04e-06	2.69e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Gene Expression—AKT1—hypertension	5.03e-06	2.68e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—RELA—hypertension	5.03e-06	2.68e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—EGFR—hypertension	5.02e-06	2.68e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—EGFR—hypertension	5.02e-06	2.68e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—EGFR—hypertension	5.02e-06	2.68e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MTOR—hypertension	5e-06	2.67e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MTOR—hypertension	5e-06	2.67e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MTOR—hypertension	5e-06	2.67e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HBA1—hypertension	4.97e-06	2.65e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—EGFR—hypertension	4.95e-06	2.64e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CYP11A1—hypertension	4.94e-06	2.64e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MTOR—hypertension	4.93e-06	2.63e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—EP300—hypertension	4.93e-06	2.63e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—EP300—hypertension	4.93e-06	2.63e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—EP300—hypertension	4.93e-06	2.63e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—EP300—hypertension	4.86e-06	2.59e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTT1—hypertension	4.85e-06	2.59e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SLC9A1—hypertension	4.85e-06	2.59e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CXCL8—hypertension	4.81e-06	2.56e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CXCL8—hypertension	4.81e-06	2.56e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CXCL8—hypertension	4.81e-06	2.56e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GCLC—hypertension	4.8e-06	2.56e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CETP—hypertension	4.8e-06	2.56e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MYC—hypertension	4.74e-06	2.53e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CXCL8—hypertension	4.74e-06	2.53e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TGFB1—hypertension	4.73e-06	2.52e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MYC—hypertension	4.72e-06	2.52e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hypertension	4.71e-06	2.51e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TGFB1—hypertension	4.7e-06	2.51e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—AKT1—hypertension	4.69e-06	2.5e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—AKT1—hypertension	4.67e-06	2.49e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—EGFR—hypertension	4.63e-06	2.47e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—EGFR—hypertension	4.61e-06	2.46e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CYP17A1—hypertension	4.6e-06	2.45e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ENO1—hypertension	4.55e-06	2.43e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTGS1—hypertension	4.55e-06	2.43e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CTGF—hypertension	4.38e-06	2.34e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MMP9—hypertension	4.35e-06	2.32e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MMP9—hypertension	4.35e-06	2.32e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MMP9—hypertension	4.35e-06	2.32e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GOT2—hypertension	4.34e-06	2.32e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HMGCR—hypertension	4.34e-06	2.32e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CDKN1A—hypertension	4.33e-06	2.31e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CDKN1A—hypertension	4.33e-06	2.31e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CDKN1A—hypertension	4.33e-06	2.31e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PTEN—hypertension	4.32e-06	2.31e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PTEN—hypertension	4.32e-06	2.31e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PTEN—hypertension	4.32e-06	2.31e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MMP9—hypertension	4.29e-06	2.29e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CDKN1A—hypertension	4.27e-06	2.28e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PTEN—hypertension	4.26e-06	2.27e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—ALB—hypertension	4.25e-06	2.27e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ADRA2A—hypertension	4.25e-06	2.27e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MAPK8—hypertension	4.23e-06	2.26e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MAPK8—hypertension	4.23e-06	2.26e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MAPK8—hypertension	4.23e-06	2.26e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL6—hypertension	4.18e-06	2.23e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL6—hypertension	4.18e-06	2.23e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL6—hypertension	4.18e-06	2.23e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MAPK8—hypertension	4.17e-06	2.22e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—EP300—hypertension	4.12e-06	2.2e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—EP300—hypertension	4.12e-06	2.2e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—EP300—hypertension	4.12e-06	2.2e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL6—hypertension	4.12e-06	2.2e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—EP300—hypertension	4.06e-06	2.17e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—SRC—hypertension	4.01e-06	2.14e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—SRC—hypertension	4.01e-06	2.14e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—SRC—hypertension	4.01e-06	2.14e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—TH—hypertension	3.98e-06	2.12e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CALM2—hypertension	3.96e-06	2.11e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—SRC—hypertension	3.95e-06	2.11e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—AKT1—hypertension	3.93e-06	2.1e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—AKT1—hypertension	3.91e-06	2.09e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—VEGFA—hypertension	3.9e-06	2.08e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—VEGFA—hypertension	3.9e-06	2.08e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—VEGFA—hypertension	3.9e-06	2.08e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TP53—hypertension	3.89e-06	2.08e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TP53—hypertension	3.87e-06	2.07e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SLC2A4—hypertension	3.87e-06	2.06e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GCG—hypertension	3.87e-06	2.06e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—IL6—hypertension	3.85e-06	2.06e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—IL6—hypertension	3.85e-06	2.06e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—IL6—hypertension	3.85e-06	2.06e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—AKT1—hypertension	3.85e-06	2.05e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—AKT1—hypertension	3.85e-06	2.05e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—AKT1—hypertension	3.85e-06	2.05e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—VEGFA—hypertension	3.85e-06	2.05e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—AKT1—hypertension	3.83e-06	2.04e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—AKT1—hypertension	3.83e-06	2.04e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—AKT1—hypertension	3.83e-06	2.04e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—IL6—hypertension	3.8e-06	2.03e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—AKT1—hypertension	3.8e-06	2.03e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—AKT1—hypertension	3.78e-06	2.01e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GOT1—hypertension	3.75e-06	2e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CYP19A1—hypertension	3.64e-06	1.94e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—STK11—hypertension	3.64e-06	1.94e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MYC—hypertension	3.59e-06	1.92e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MYC—hypertension	3.59e-06	1.92e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MYC—hypertension	3.59e-06	1.92e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TGFB1—hypertension	3.58e-06	1.91e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TGFB1—hypertension	3.58e-06	1.91e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TGFB1—hypertension	3.58e-06	1.91e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL6—hypertension	3.56e-06	1.9e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—AKT1—hypertension	3.56e-06	1.9e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—AKT1—hypertension	3.56e-06	1.9e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—AKT1—hypertension	3.56e-06	1.9e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL6—hypertension	3.54e-06	1.89e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MYC—hypertension	3.54e-06	1.89e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TGFB1—hypertension	3.53e-06	1.88e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—EGFR—hypertension	3.51e-06	1.87e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—EGFR—hypertension	3.51e-06	1.87e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—EGFR—hypertension	3.51e-06	1.87e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—AKT1—hypertension	3.51e-06	1.87e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—EGFR—hypertension	3.46e-06	1.85e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—COMT—hypertension	3.38e-06	1.8e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PPARGC1A—hypertension	3.33e-06	1.78e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GNB3—hypertension	3.33e-06	1.78e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HMOX1—hypertension	3.32e-06	1.77e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—AKT1—hypertension	3.29e-06	1.75e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CAT—hypertension	3.27e-06	1.75e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—AKT1—hypertension	3.27e-06	1.74e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GNAS—hypertension	3.25e-06	1.73e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APOB—hypertension	3.18e-06	1.7e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTM1—hypertension	3.09e-06	1.65e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—LPL—hypertension	3.04e-06	1.62e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—AKT1—hypertension	2.98e-06	1.59e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—AKT1—hypertension	2.98e-06	1.59e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—AKT1—hypertension	2.98e-06	1.59e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ADCY5—hypertension	2.97e-06	1.59e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GPX1—hypertension	2.96e-06	1.58e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TP53—hypertension	2.95e-06	1.57e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TP53—hypertension	2.95e-06	1.57e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TP53—hypertension	2.95e-06	1.57e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—AKT1—hypertension	2.94e-06	1.57e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CYP1A1—hypertension	2.93e-06	1.56e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PRKCA—hypertension	2.93e-06	1.56e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TP53—hypertension	2.91e-06	1.55e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CD36—hypertension	2.88e-06	1.54e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—MTHFR—hypertension	2.73e-06	1.46e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL6—hypertension	2.7e-06	1.44e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL6—hypertension	2.7e-06	1.44e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL6—hypertension	2.7e-06	1.44e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PPARA—hypertension	2.68e-06	1.43e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL6—hypertension	2.66e-06	1.42e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—AGT—hypertension	2.6e-06	1.39e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CALM1—hypertension	2.55e-06	1.36e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APOE—hypertension	2.54e-06	1.36e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CAV1—hypertension	2.52e-06	1.34e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—APOA1—hypertension	2.52e-06	1.34e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—AKT1—hypertension	2.49e-06	1.33e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—AKT1—hypertension	2.49e-06	1.33e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—AKT1—hypertension	2.49e-06	1.33e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—AKT1—hypertension	2.46e-06	1.31e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PPARG—hypertension	2.22e-06	1.18e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—POMC—hypertension	2.19e-06	1.17e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—INS—hypertension	2.17e-06	1.16e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALB—hypertension	1.99e-06	1.06e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PIK3R1—hypertension	1.91e-06	1.02e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—NOS3—hypertension	1.91e-06	1.02e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTGS2—hypertension	1.74e-06	9.3e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTEN—hypertension	1.52e-06	8.11e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—EP300—hypertension	1.45e-06	7.73e-06	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—AKT1—hypertension	8.76e-07	4.67e-06	CbGpPWpGaD
